doi: 10.1016/j.nmd.2018.02.003.
Epub 2018 Feb 12.
222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016
Collaborators,
Affiliations
- PMID: 29550152
- DOI: 10.1016/j.nmd.2018.02.003
Item in Clipboard
222nd ENMC International Workshop:: Myotonic dystrophy, developing a European consortium for care and therapy, Naarden, The Netherlands, 1-2 July 2016
Neuromuscul Disord.
2018 May.
No abstract available
Similar articles
-
123rd ENMC International Workshop: management and therapy in myotonic dystrophy, 6-8 February 2004, Naarden, The Netherlands.Neuromuscul Disord. 2005 May;15(5):389-94. doi: 10.1016/j.nmd.2005.02.001. Neuromuscul Disord. 2005. PMID: 15833434 No abstract available.
-
99th ENMC international workshop: myotonic dystrophy: present management, future therapy. 9-11 November 2001, Naarden, The Netherlands.Neuromuscul Disord. 2002 Aug;12(6):596-9. doi: 10.1016/s0960-8966(02)00020-2. Neuromuscul Disord. 2002. PMID: 12117486 No abstract available.
-
114th ENMC International Workshop on Congenital Muscular Dystrophy (CMD) 17-19 January 2003, Naarden, The Netherlands: (8th Workshop of the International Consortium on CMD; 3rd Workshop of the MYO-CLUSTER project GENRE).Neuromuscul Disord. 2003 Sep;13(7-8):579-88. doi: 10.1016/s0960-8966(03)00072-5. Neuromuscul Disord. 2003. PMID: 12921796 No abstract available.
-
117th ENMC workshop: ventilatory support in congenital neuromuscular disorders -- congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 April 2003, Naarden, The Netherlands.Neuromuscul Disord. 2004 Jan;14(1):56-69. doi: 10.1016/j.nmd.2003.09.003. Neuromuscul Disord. 2004. PMID: 14659414 Review. No abstract available.
-
108th ENMC International Workshop, 3rd Workshop of the MYO-CLUSTER project: EUROMEN, 7th International Emery-Dreifuss Muscular Dystrophy (EDMD) Workshop, 13-15 September 2002, Naarden, The Netherlands.Neuromuscul Disord. 2003 Aug;13(6):508-15. doi: 10.1016/s0960-8966(03)00063-4. Neuromuscul Disord. 2003. PMID: 12899879 Review. No abstract available.
Cited by
-
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1.Front Neurol. 2020 Oct 7;11:624. doi: 10.3389/fneur.2020.00624. eCollection 2020. Front Neurol. 2020. PMID: 33117249 Free PMC article. Review.
-
[Innovative therapeutic approaches for hereditary neuromuscular diseases].Nervenarzt. 2018 Oct;89(10):1115-1122. doi: 10.1007/s00115-018-0599-9. Nervenarzt. 2018. PMID: 30171303 Review. German.
-
The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care.Orphanet J Rare Dis. 2019 Jun 3;14(1):122. doi: 10.1186/s13023-019-1088-3. Orphanet J Rare Dis. 2019. PMID: 31159885 Free PMC article.
-
Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.Patient. 2019 Aug;12(4):365-373. doi: 10.1007/s40271-019-00357-y. Patient. 2019. PMID: 30714084 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
